<?xml version="1.0" encoding="UTF-8"?>
<p>HBV remains a global public health issue. A recent, large epidemiologic pooled analysis of 161 countries found HBV surface antigen (HBsAg) prevalence of 3.61%, comprising 248 million chronically infected individuals and ranging between 0.20% in the Americas to 22.38% in Africa. In the United States, HBsAg seroprevalence was 0.27%, corresponding to 843,724 individuals with chronic HBV infection.
 <xref rid="hep41480-bib-0045" ref-type="ref">45</xref>
</p>
